|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.48 CAD||-0.01 (-1.03%)||0.18 - 1.04||102.2 thousand (Below Avg)|
Market data as of 3:59PM 07/30/14. Quotes are delayed by at least 15 min.
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
PR Newswire - Monday 07/28/2014 7:00 AM ET
Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014
PR Newswire - Tuesday 07/15/2014 4:46 PM ET
Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing
PR Newswire - Tuesday 07/15/2014 4:28 PM ET
Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast
PR Newswire - Thursday 07/10/2014 7:00 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.